ZA947962B - Molecules influencing the shedding of the TNF receptor their preparation and their use - Google Patents

Molecules influencing the shedding of the TNF receptor their preparation and their use

Info

Publication number
ZA947962B
ZA947962B ZA947962A ZA947962A ZA947962B ZA 947962 B ZA947962 B ZA 947962B ZA 947962 A ZA947962 A ZA 947962A ZA 947962 A ZA947962 A ZA 947962A ZA 947962 B ZA947962 B ZA 947962B
Authority
ZA
South Africa
Prior art keywords
shedding
preparation
tnf receptor
tnf
molecules
Prior art date
Application number
ZA947962A
Other languages
English (en)
Inventor
David Wallach
Cord Brakebusch
Eugene Varfolomeev
Michael Batkin
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA947962B publication Critical patent/ZA947962B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
ZA947962A 1993-10-12 1994-10-12 Molecules influencing the shedding of the TNF receptor their preparation and their use ZA947962B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL107268A IL107268A0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use

Publications (1)

Publication Number Publication Date
ZA947962B true ZA947962B (en) 1995-11-21

Family

ID=11065340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947962A ZA947962B (en) 1993-10-12 1994-10-12 Molecules influencing the shedding of the TNF receptor their preparation and their use

Country Status (13)

Country Link
US (2) US5665859A (de)
EP (1) EP0657536B1 (de)
JP (1) JPH07194376A (de)
AT (1) ATE203273T1 (de)
AU (1) AU679559B2 (de)
CA (1) CA2133872A1 (de)
DE (1) DE69427740T2 (de)
DK (1) DK0657536T3 (de)
ES (1) ES2163418T3 (de)
GR (1) GR3036782T3 (de)
IL (1) IL107268A0 (de)
PT (1) PT657536E (de)
ZA (1) ZA947962B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03164179A (ja) * 1989-04-21 1991-07-16 Boehringer Ingelheim Internatl Gmbh Ｔｎｆレセプター、ｔｎｆ結合たん白質およびこれらをコードするｄｎａ
US7264944B1 (en) * 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6930084B1 (en) 1996-11-06 2005-08-16 The Regents Of The University Of California Treating arthritis with TNF receptor releasing enzyme
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
US6989435B2 (en) * 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6406907B1 (en) * 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
WO2001064856A2 (en) * 2000-02-28 2001-09-07 The Government Of The United States Of America, A S Represented By The Secretary, Department Of Hea Lth And Human Services Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
EP1448772B1 (de) * 2001-11-30 2007-07-18 Applied Research Systems ARS Holding N.V. Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
US20070105807A1 (en) * 2005-11-10 2007-05-10 Sazani Peter L Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease
US7785834B2 (en) * 2005-11-10 2010-08-31 Ercole Biotech, Inc. Soluble TNF receptors and their use in treatment of disease
US8268635B2 (en) * 2006-05-19 2012-09-18 Antonio Ferrante Methods of identifying agents that selectively activate p38 and/or NKkB signaling
US20090264353A1 (en) * 2007-10-19 2009-10-22 Santaris Pharma A/S Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
WO2011049350A2 (ko) * 2009-10-19 2011-04-28 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법
US10723532B2 (en) 2017-05-22 2020-07-28 Bedford Insutries, Inc. Elastic band package
US11021339B2 (en) 2017-05-22 2021-06-01 Bedford Industries, Inc. Elastic band dispenser

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101769A (en) * 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action

Also Published As

Publication number Publication date
JPH07194376A (ja) 1995-08-01
DK0657536T3 (da) 2001-09-17
EP0657536A1 (de) 1995-06-14
CA2133872A1 (en) 1995-04-13
PT657536E (pt) 2001-12-28
US5766917A (en) 1998-06-16
GR3036782T3 (en) 2002-01-31
US5665859A (en) 1997-09-09
DE69427740D1 (de) 2001-08-23
ATE203273T1 (de) 2001-08-15
AU679559B2 (en) 1997-07-03
DE69427740T2 (de) 2002-05-23
IL107268A0 (en) 1994-01-25
AU7574294A (en) 1995-05-04
EP0657536B1 (de) 2001-07-18
ES2163418T3 (es) 2002-02-01

Similar Documents

Publication Publication Date Title
IL107268A0 (en) Molecules influencing the shedding of the tnf receptor, their preparation and their use
DE69435198D1 (de) "hedgehog-like" proteine von wirbeltieren, die embryonale strukturen induzieren
AU5901994A (en) Tumor necrosis factor muteins
WO1999012965A3 (en) April- a novel protein with growth effects
MY102025A (en) Improvements in or relating to novel difluoro antiviral agents
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
CA2163361A1 (en) Therapeutic substituted guanidines
IL128407A0 (en) A tumor necrosis factor related ligand
AU8143894A (en) Mck-10 (mammary carcinoma kinase 10), a receptor tyrosine kinase
BR9611897A (pt) Benzofurano carboxamidas e sulfonamidas
UA85365C2 (ru) Продукт конъюгирования цитокина для использования в противораковой терапии
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
FR2701264B1 (fr) Muteines de facteur de necrose tumorale.
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
WO1990006943A3 (de) Neue tnf-peptide
AU7574394A (en) TNF inhibitors
AU7117687A (en) Combination therapy using interleukin-2 and tumor necrosis factor
ITTO920516A0 (it) Procedimento ed apparecchiatura per la rpoduzione, in particolare domestica, di bevande.
MY114693A (en) Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them
AP9701142A0 (en) 4,4-(Disubstituted) cyclohexan-1-ols monomers and related compounds.
DE69432444D1 (de) Promotor-Sequenz des Rezeptors p55 für Tumor-Nekrosis-Faktor
ZA918116B (en) Inhibitors for the formation of tumor necrosis factor,processes for the preparation thereof and the use thereof
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
IT8721683A0 (it) Procedimento per la reidratazione rapida di legumi e simili, nonche'apparecchiatura per la reidratazione rapida ed in continuov di legumi e simili.